Evidence map›Paper›PMID 21539318›Full record

ArticleJournal of the American Chemical Society2011

Antisense and antigene inhibition of gene expression by cell-permeable oligonucleotide-oligospermine conjugates.

Keith T Gagnon, Jonathan K Watts, Hannah M Pendergraff, Christophe Montaillier, Danielle Thai, Pierre Potier, David R Corey

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Keith T GagnonDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Jonathan K Watts
Hannah M Pendergraff
Christophe Montaillier
Danielle Thai
Pierre Potier
David R Corey
The University of Texas Southwestern Medical Center · USGenopole (France) · FR

Funding

Recognition of Chromosomal DNA by Peptide Nucleic AcidsR01GM073042 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI COREY, DAVID R · 2005 to 2016
$3.5M
Activating Gene Expression with Antigene RNAs to Treat Genetic DiseasesF32HD060377 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI GAGNON, KEITH THOMAS · 2009 to 2012
$152k
NICHD NIH HHS 1F32HD060377NICHD NIH HHS F32 HD060377NIGMS NIH HHS GM 73042NIGMS NIH HHS R01 GM073042
6 · The paper itself

Abstract

Oligonucleotides and their derivatives are a proven chemical strategy for modulating gene expression. However, their negative charge remains a challenge for delivery and target recognition inside cells. Here we show that oligonucleotide-oligospermine conjugates (Zip nucleic acids or ZNAs) can help overcome these shortcomings by serving as effective antisense and antigene agents. Conjugates containing DNA and locked nucleic acid (LNA) oligonucleotides are active, and oligospermine conjugation facilitates carrier-free cell uptake at nanomolar concentrations. Conjugates targeting the CAG triplet repeat within huntingtin (HTT) mRNA selectively inhibit expression of the mutant huntingtin protein. Conjugates targeting the promoter of the progesterone receptor (PR) function as antigene agents to block PR expression. These observations support further investigation of ZNA conjugates as gene silencing agents.

Indexed as

Base SequenceCationsCell Membrane PermeabilityDrug Delivery SystemsEnzyme InhibitorsGene Expression RegulationGene Transfer TechniquesInhibitory Concentration 50Models, BiologicalModels, MolecularMolecular Sequence DataMolecular StructureOligonucleotidesOligonucleotides, AntisenseSpermineCationsEnzyme InhibitorsOligonucleotidesOligonucleotides, AntisenseSpermine

Identifiers

PMID21539318
PMCPMC3106116
OpenAlexW2050021894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.